Skip to main content

Table 2 Demographics of patient cases

From: Impact of a bronchial genomic classifier on clinical decision making in patients undergoing diagnostic evaluation for lung cancer

Variable (n = 36)
Sex
 Male 24 (67 %)
 Female 12 (33 %)
Age, median (IQR) 60.5 (23.2)
Race
 Caucasian 32 (89 %)
 African American 3 (8 %)
 Other 1 (3 %)
Smoking Status
 Former 22 (61 %)
 Current 14 (39 %)
Pack-years, median (IQR) 39.0 (33.7)
Lesion size
 < 2 cm 19 (53 %)
 2 to 3 cm 5 (14 %)
 ≥ 3 cm 7 (19 %)
 Ill-defined infiltrate 5 (14 %)
Lesion location
 Peripheral 18 (50 %)
 Central 7 (19 %)
 Both 10 (28 %)
 Unknown 1 (3 %)
Lung cancer histology 12 (33 %)
 Non-small cell 11 (92 %)
  Adenocarcinoma 8 (73 %)
  Squamous 2 (18 %)
  NSCLC other 1 (9 %)
 Small cell 1 (8 %)
Benign diagnoses 24 (67 %)
 Infection 8 (33 %)
 Resolution or stability 7 (29 %)
 Sarcoidosis 1 (4 %)
 Other 8 (33 %)